Robert E. Holt

Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.

Ik–Kyung Jang, Herman K. Gold, Andrew A. Ziskind et al. · Circulation · 1989 · 554 citations

Platelet-rich Arterial Thrombi, Biomedical Engineering, Acute Myocardial Infarction +17

Increased Plasminogen Activator Inhibitor Type 1 in Coronary Artery Atherectomy Specimens From Type 2 Diabetic Compared With Nondiabetic Patients

Burton E. Sobel, Janet Woodcock‐Mitchell, David J. Schneider et al. · Circulation · 1998 · 272 citations · Full text

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.

Herman K. Gold, Lawrence W. Gimple, Tsunehiro Yasuda et al. · Journal of Clinical Investigation · 1990 · 178 citations · Full text

Immunology, Pharmacotherapy, Platelet Aggregation +17

Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation

Tsunehiro Yasuda, Herman K. Gold, Hiroyuki Yaoita et al. · Journal of the American College of Cardiology · 1990 · 134 citations

Thrombosis, Cardiovascular Disease, Coronary Artery Reperfusion +14

Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody

Tsunehiro Yasuda, Herman K. Gold, Robert C. Leinbach et al. · Journal of the American College of Cardiology · 1990 · 120 citations

Thrombopoiesis, Thrombosis, Antiplatelet Gpiib/iiia Antibody +10